Hematologic Function
Hematologic Function
HEMATOLOGY
- The study of blood and blood-forming tissues. this includes
bone marrow, blood, spleen, & lymph system.
Consists of the:
• Blood
• Blood Production Sites
✓ Bone marrow
✓ Reticuloendothelial system (RES)
• Protection
✓ Maintaining homeostasis of blood coagulation.
✓ Combating invasion of pathogens and other foreign
substances.
2 MAJOR COMPONENTS
• Plasma
• Blood cells
→ Primitive cells.
→ Have the ability to self-replicate.
→ When stimulated, it undergoes differentiation.
Self-replicate
Functions:
• Primary Hemostasis
• Secondary Hemostasis
• Coagulation Cascade
Albumin: ________________________________________
SKIN
Findings Potential Indications
GRAY-TAN OR BRONZE Hemochromatosis
SKIN COLOR (primary or secondary)
(especially genitalia, scars,
exposed areas)
-------------------------ASSESSMENT-------------------------
SKIN
Findings Potential Indications
RUDDY COMPLEXION Polycythemia
Family History Assessment Specific to Hematologic Disorders (face, conjunctiva, hands, feet)
• Maternal and paternal relatives from three generations of
the family.
• Blood disorders or episodes of abnormal bleeding.
HEMATOLOGIC DISORDERS
- Are marked by aberrations in the structure or function of
the blood cells or the blood clotting mechanism.
Autosomal Dominant:
• Factor V Leiden SKIN
• Familial hypercholesterolemia Findings Potential Indications
• Hereditary angioedema PETECHIAE Severe thrombocytopenia
(pinpoint hemorrhagic lesions,
• Hereditary spherocytosis
usually more prominent on
• Von Willebrand disease
trunk or anterior aspects of
lower extremities)
Autosomal Recessive:
ECCHYMOSES Thrombocytopenia,
• Hemochromatosis
Coagulopathy
• Sickle cell disease
• Thalassemia
X-Linked:
• Hemophilia
SKIN RESPIRATORY
Findings Potential Indications Findings Potential Indications
RASH If pruritic, may indicate Increased rate and depth of Anemia; Infection
polycythemia. respirations; presence of
BLEEDING Thrombocytopenia, adventitious breath sound
(including around the vascular Coagulopathy
lines, tubes)
CONJUNCTIVAL Severe thrombocytopenia, CARDIOVASCULAR
HEMORRHAGE Coagulopathy Findings Potential Indications
Distended neck veins, edema, Severe anemia;
chest pain on exertion, Polycythemia
murmurs, gallops
GENITOURINARY
Findings Potential Indications
Hematuria Hemolysis;
SKIN Thrombocytopenia
Findings Potential Indications
PALLOR Anemia
MUSCULOSKELETAL
(in mucous membranes,
Findings Potential Indications
conjunctiva, nail beds)
Pain/swelling in knees, wrists, Hemophilia;
JAUNDICE Hemolysis
hands Sickle cell disease
(in mucous membranes,
conjunctiva, nail beds, palate)
ABDOMINAL
Findings Potential Indications
Stool positive for occult blood Anemia;
Thrombocytopenia
ABDOMINAL
Findings Potential Indications
PNS/CNS Dysfunction Vitamin 12 deficiency
(sensory)
Visual changes, headache, Severe thrombocytopenia
ORAL CAVITY alteration in mental status
Findings Potential Indications
SMOOTH Pernicious anemia
(tongue) GYNECOLOGIC
BEEFY RED Vitamin B12/ or folate Findings Potential Indications
(tongue) deficiency Menorrhagia Thrombocytopenia;
ENLARGED TONGUE Amyloidosis Coagulopathy
GENERAL
Findings Potential Indications
Fever, chills, sweats, asthenia Leukemia; Lymphoma;
Infection
----------------DIAGNOSTIC EVALUATION---------------
ORAL CAVITY
Findings Potential Indications COMPLETE BLOOD COUNT (CBC)
ANGULAR CHEILOSIS Anemia • Obtained via venipuncture.
(ulceration at the corners of • Identifies the following:
the mouth) ✓ Total number of cells (leukocytes, erythrocytes
ENLARGED GUMS; Leukemia and platelets).
HYPERPLASIA ✓ Hemoglobin
PETECHIAE Severe thrombocytopenia ✓ Hematocrit (percentage of blood volume
(buccal, mucosa, gingiva, hard consisting of erythrocytes)
palate) ✓ RBC indices
Needle
Stylet is removed
INDICATIONS
• Evaluating a patient’s clotting ability.
• Monitoring the therapeutic effectiveness of anticoagulant
medications.
PROCEDURE
• In both tests, specific reagents are mixed into the plasma
sample, and the time taken to form a clot is measured.
PURPOSE
• To assess how a patient’s blood cells are being formed.
• To assess the quantity and quality of each type of cell
produced within the marrow.
• To document infection or tumor within the marrow.
PATIENT PREPARATION
• Signed informed consent.
• Skin (site) preparation.
• Anxiolytic agent (for anxious patients).
• Administration of local anesthetic agent (skin & subQ to
the periosteum of the bone → it is not possible to
anesthetize the bone itself).
Pressure is applied to the site for several minutes Blood is taken from the patient, passed through a centrifuge
Site is then covered with a sterile dressing. A specific component is separated from the blood
→ To remove platelets.
→ Examples of Clinical Use
• Extreme thrombocytosis, essential
thrombocythemia (temporary measure)
• Single-donor platelet transfusion
→ To remove RBCs.
→ Examples of Clinical Use
• RBC dyscrasias (e.g., sickle cell disease)
• RBCs replaced via transfusion